Dose-ranging Study of Nemolizumab in Atopic Dermatitis

Clinical trial NCT03100344 · COMPLETED

Trial details

NCT number: NCT03100344
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2017-06-14
Primary completion: 2018-07-19
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.